Login to Your Account



Ark Delays Initial Public Offering Due To Unfavorable Conditions

By Nuala Moran


Wednesday, May 22, 2002
LONDON - Ark Therapeutics Group plc postponed its initial public offering on the London Stock Market, blaming "unusually adverse market conditions." (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription